- Total income
- ₹13,171 Cr
- Profit
- ₹1,768 Cr

Dabur
About Dabur
Dabur is a publicly listed company based in Delhi (India) founded in 1884. Manufacturer of ayurvedic medicine and natural consumer products. Dabur has raised $42.18 million across 4 funding rounds from investors including Baring Private Equity Partners. The company has 4,770 employees. Dabur has completed 6 acquisitions, including Asian Consumer Care, Badshah Masala and Balsara Home Products. Its chief executive, as recorded, is Mohit Malhotra. Its website dabur.com draws about 388 thousand monthly visits. Its Indian entity Dabur India Limited reported revenue of βΉ9,861 Cr. Its focus areas include Consumer Goods, Beauty & Personal Care Products, Multi Category and Natural. Its competitors include Mamaearth, WOW Skin Science and The Body Shop India; 2 of its 3 listed competitors have raised funding.
Company details
Dabur was founded in 1884 in Delhi, India, and operates in the ayurvedic medicine and natural consumer products sector. A diverse portfolio is produced, encompassing skincare, haircare, healthcare, and oral care items. Offerings include hair oil, toothpaste, churna, chyawanprash, honey, rose water, tea, cough syrup, health juices, skin care products, and baby care essentials. Operations focus on traditional formulations for everyday health and personal needs.
Dabur is ranked #207 on the Fortune India 500 (2025) and #87 among India's most valuable companies (2025).
Recognitions & Rankings of Dabur
- Valuation
- ₹78,310 Cr
- Market Cap₹67,911 Cr
DABUR · NSE
- Share Price₹375.25
-1.97% today
- Revenue₹13,193 Cr
FY 2025-26 · +5.0% YoY
- EBITDA₹2,435 Cr
Margin 18.5%
- Net Profit₹1,888 Cr
FY 2025-26 · +7.5% YoY
- P/E (TTM)33.1x
P/B 5.9x
- ROE16.8%
ROCE 20.9%
- Debt / Equity0.10
Interest cover 7.4x
- Total Equity Funding$42.18M (USD)
in 4 rounds
- Latest Funding Round$9.03M (USD), Angel Round
Mar 2024
- Investors
- Employee Count4,770
- Investments & AcquisitionsAsian Consumer Care
& 5 more
Associated legal entities of Dabur
Dabur is associated with 19 registered companies on The Company Check; the primary company is Dabur India Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Dabur India Limited Listed CIN L24230DL1975PLC007908 | Active | 16 Sep 1975 | New Delhi, Delhi | ₹9,861 Cr | 5,738 | 15 | View details |
| Malhotras Trading Co Pvt Ltd CIN U70101DL1945PTC318797 | Active | 13 Sep 1945 | Delhi, Delhi | ₹0.1 Cr | 3 | View details | |
| Burman Resorts Private Limited CIN U55101DL2003PTC118827 | Active | 06 Feb 2003 | New Delhi, Delhi | ₹0.9 Cr | 2 | View details | |
| Althea Drf Lifesciences Limited CIN U33110DL2008PLC185857 | Active | 16 Dec 2008 | New Delhi, Delhi | ₹17.3 Cr | 10 | 7 | View details |
| Dabur Securities Private Limited CIN U74899DL1995PTC064350 | Active | 13 Jan 1995 | Delhi, Delhi | ₹7.2 Cr | 13 | 4 | View details |
| Dabur Ayurvedic Specialities Limited CIN U74899DL1993PLC054964 | Active | 25 Aug 1993 | New Delhi, Delhi | ₹0.0 Cr | 3 | View details | |
| Sahiwal Investment And Trading Company CIN U70102DL1981ULT165522 | Active | 30 Jan 1981 | New Delhi, Delhi, India | View details | |||
| Dabur Pharmaceutical Ltd CIN U24231DL1985PLC021308 | Active | 25 Jun 1985 | New Delhi, Delhi, India | View details | |||
| Sunshine India Private Limited CIN U70100DL1996PTC079692 | Active | 17 Jun 1996 | New Delhi, Delhi, India | View details | |||
| Param Investments Private Limited CIN U70100DL1984PTC019414 | Active | 27 Nov 1984 | New Delhi, Delhi, India | View details | |||
| A. V. B. Finance Private Limited. CIN U68100DL1992PTC049818 | Active | 04 Aug 1992 | New Delhi, Delhi, India | View details | |||
| Burmans Finvest Private Limited CIN U65100DL1989PTC034593 | Active | 09 Jan 1989 | New Delhi, Delhi, India | View details | |||
| Milky Investment And Trading Company CIN U65100DL1981ULT165402 | Active | 30 Jan 1981 | New Delhi, Delhi, India | $13.5M | View details | ||
| V I C Enterprises Private Ltd. CIN U65100DL1979PTC021613 | Active | 03 Mar 1979 | New Delhi, Delhi, India | View details | |||
| Ratna Commercial Enterprises Private Ltd. CIN U65100DL1979PTC021610 | Active | 03 Mar 1979 | Delhi, India | $18.7M | View details | ||
| Windy Investments Private Limited CIN U65100DL1978PTC167481 | Active | 17 Jun 1978 | Delhi, India | $60.7M | View details | ||
| Passionate Foods Private Limited CIN U15135DL2011PTC218825 | Active | 09 May 2011 | New Delhi, Delhi, India | View details | |||
| Northern Herbal Farms Private Limited CIN U01122DL2003PTC122486 | Active | 03 Oct 2003 | Delhi, India | View details | |||
| Super Hoze Industries Private Limited CIN U34300DL2005PTC133336 | Active | 24 Feb 2005 | New Delhi, Delhi, India | View details |
Apps and channels of Dabur
its YouTube channel DaburIndiaLtd has 5.67K subscribers and 30 videos.
Videos from Dabur
The most watched videos on Dabur's YouTube channel, DaburIndiaLtd (5.67K subscribers). Click a video to play it here.
More on DaburIndiaLtd.
Funding Insights of Dabur
Dabur has successfully raised a total of $42.18M across 4 strategic funding rounds. The most recent funding activity was a Angel Round of $9.03 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $42.18M
- Total Rounds 4
- Last Round Angel Round β $9.03M
- First Round $45M
(Jun 2012)
- Investors Count 1
All 4 funding rounds of Dabur with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2024 | $9.03M | Angel Round | β | β | β |
| Nov 2023 | $33.16M | Angel Round | β | β | β |
| Apr 2013 | $18M | Post-IPO | β | β | |
| Jun 2012 | $45M | Post-IPO | β | β |
1 investors in total: 1 institutional.
Investors in Dabur
Dabur has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Baring Private Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focusing on buyouts and investments in multiple sectors | 1998 | bpepindia.com | Mumbai, India |
Investor details for Dabur
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Dabur India Limited (Dabur)
Dabur India Limited is the primary company behind Dabur. The boards of the 6 registered companies of Dabur currently have 25 directors; the longest-serving is Pritam Das Narang, appointed in 1998. 55 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pritam Das Narang DIN 00021581 | Whole-time director | 01 Apr 1998 | 28 yrs 7 mo | Dabur India Limited |
| Ashok Kumar Jain DIN 00042902 | Director | 17 Aug 1999 | 27 yrs 2 mo | Dabur Securities Private Limited, Malhotras Trading Co Pvt Ltd |
| Mohit Burman DIN 00021963 | Director | 18 Oct 2001 | 25 yrs | Malhotras Trading Co Pvt Ltd, Dabur India Limited |
| Amit Burman DIN 00042050 | Director | 01 Nov 2001 | 25 yrs | Dabur India Limited |
| Abhay Kumar Agarwal DIN 00042882 | Director | 25 Jul 2007 | 19 yrs 3 mo | Dabur Securities Private Limited |
| Ajay Kumar Marwah DIN 00042822 | Director | 20 Aug 2008 | 18 yrs 2 mo | Malhotras Trading Co Pvt Ltd |
| Ajay Kumar Vij DIN 00164984 | Director | 16 Dec 2008 | 17 yrs 10 mo | Althea Drf Lifesciences Limited |
| Vivek Chand Burman DIN 00041962 | Director | 01 Jan 2011 | 15 yrs 10 mo | Dabur Securities Private Limited, Dabur Ayurvedic Specialities Limited |
| Anand Chand Burman DIN 00056216 | Director | 14 Apr 2011 | 15 yrs 6 mo | Dabur Securities Private Limited |
| Saket Burman DIN 05208674 | Director | 31 Jan 2012 | 14 yrs 9 mo | Dabur India Limited |
| Minnie Burman DIN 02614903 | Director | 05 Mar 2012 | 14 yrs 8 mo | Althea Drf Lifesciences Limited |
| Mohit Malhotra DIN 08346826 | Whole-time director | 31 Jan 2019 | 7 yrs 9 mo | Dabur India Limited |
| Ajit Mohan Sharan DIN 02458844 | Director | 31 Jan 2019 | 7 yrs 9 mo | Dabur India Limited |
| Anurag Gupta DIN 07138649 | Director | 06 Mar 2019 | 7 yrs 8 mo | Althea Drf Lifesciences Limited |
| Aditya Chand Burman DIN 00042277 | Director | 19 Jul 2019 | 7 yrs 3 mo | Dabur India Limited |
| Mukesh Hari Butani DIN 01452839 | Director | 01 Jan 2021 | 5 yrs 10 mo | Dabur India Limited |
| Rajiv Mehrishi DIN 00208189 | Director | 01 Sep 2021 | 5 yrs 2 mo | Dabur India Limited |
| Akhil Mahajan DIN 09288584 | Director | 21 Mar 2022 | 4 yrs 7 mo | Dabur Ayurvedic Specialities Limited |
| Satyavati Berera DIN 05002709 | Director | 01 Jun 2023 | 3 yrs 5 mo | Dabur India Limited |
| Romesh Sobti DIN 00031034 | Director | 01 Apr 2024 | 2 yrs 7 mo | Dabur India Limited |
| Ravi Kapoor DIN 00185981 | Director | 25 Jun 2024 | 2 yrs 4 mo | Dabur India Limited |
| Manu Jaggi DIN 08351405 | Whole-time director | 24 Dec 2024 | 1 yr 10 mo | Althea Drf Lifesciences Limited |
| Nitin Garg DIN 10085072 | Additional Director | 21 Mar 2025 | 1 yr 7 mo | Dabur Ayurvedic Specialities Limited |
| Sampath Kumar DIN 11461960 | Additional Director | 27 Jan 2026 | 9 mo | Burman Resorts Private Limited |
| Sarita Agrawal DIN 11458219 | Additional Director | 27 Jan 2026 | 9 mo | Burman Resorts Private Limited |
People of Dabur
199 people are tracked at Dabur (59 in leadership, 13 in board & advisors, 127 in team); the tracked headcount is 4,770.
| Name | Role | Group |
|---|---|---|
| Owner | Leadership | |
| CEO | Leadership | |
Ashish Dixit | Unit Operation Head | Leadership |
Mandeep Singh Oberoi | Head Of Marketing | Leadership |
Manas Mehra | Global Chief Information Officer | Leadership |
Hrishikesh Ramani | Vice President | Leadership |
Tobin Pappan | Cluster Head | Leadership |
Chandan Agarwal | Head Of Tax | Leadership |
Biswaranjan Roul | Engineering Head | Leadership |
Somit Mukherjee | Senior Vice President (central Procurement & Material Supply Chain) & Chief Procurement Officer | Leadership |
Narayanan Renganathan | Vice President & Head Of Procurement | Leadership |
Deepak Gupta | Area Sales Head- West Zone | Leadership |
Birender Rana | Business Head | Leadership |
Rajiv Dubey | Vice President Marketing | Leadership |
Smerth Khanna | Head - South India And Organised Trade (mt And Ecom). | Leadership |
Dr Mandeep Singh Oberoi | Head Of Marketing | Leadership |
Prashant Agarwal | Head Of Marketing - Oral Care At Dabur India Limited | Leadership |
Anil Bothra | Vice President | Leadership |
Ajay Singh Parihar | Vice President - Healthcare & Ayurvedic Business | Leadership |
Ankush Jain | Chief Financial Officer | Leadership |
179 more people are available in the full profile.
Complete people profiles for Dabur
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Dabur
Dabur is a publicly listed company on the NSE with ticker symbol DABUR in India, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date28 Apr 1999
- Listed onNSE: DABUR
- Listed entityDabur India Limited
- Exchange sectorConsumer non-durables
- ISININE016A01026
- Share price₹388.40 (+2.55% on the day) · 2026-10-14
- Market capitalisation₹67,233 Cr
- Price to earnings35.0
- EPS (diluted, trailing year)₹11.10
- Dividend yield2.18%
- Volume (last session)2,271,891
Financials of Dabur
Exchange-reported figures of Dabur India Limited, the listed company behind Dabur (NSE: DABUR).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 13,193 | 12,563 | 12,404 | 11,530 | 10,889 | 9,562 | 8,685 |
| Revenue growth | +5.0% | +1.3% | +7.6% | +5.9% | +13.9% | +10.1% | - |
| EBITDA | 2,435 | 2,316 | 2,400 | 2,162 | 2,167 | 2,002 | 1,692 |
| EBITDA margin | +18.5% | +18.4% | +19.4% | +18.8% | +19.9% | +20.9% | +19.5% |
| Profit before tax | 2,420 | 2,258 | 2,359 | 2,219 | 2,269 | 2,056 | 1,728 |
| Net profit | 1,888 | 1,756 | 1,842 | 1,695 | 1,803 | 1,693 | 1,518 |
| Net profit margin | +14.3% | +14.0% | +14.9% | +14.7% | +16.6% | +17.7% | +17.5% |
| EPS (βΉ) | 10.68 | 9.97 | 10.40 | 9.64 | 9.84 | 9.58 | 8.18 |
| Balance sheet | |||||||
| Total assets | 13,175 | 12,234 | 11,742 | 10,685 | 9,520 | 8,274 | 7,232 |
| Net worth | 11,420 | 10,801 | 9,866 | 8,973 | 8,381 | 7,664 | 6,606 |
| Total debt | 1,287 | 950 | 1,365 | 1,174 | 1,030 | 509 | 522 |
| Cash & bank | 562 | 578 | 666 | 326 | 570 | 1,329 | 811 |
| Net working capital | 142 | 591 | 741 | 634 | 780 | 1,470 | 1,384 |
| Cash flow | |||||||
| Cash from operations | 2,579 | 1,987 | 2,013 | 1,488 | 1,802 | 2,115 | 1,614 |
| Cash from investing | (1,279) | (448) | (971) | (583) | (1,273) | (1,404) | (517) |
| Cash from financing | (1,236) | (1,405) | (1,161) | (1,035) | (490) | (613) | (1,043) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3,563 | 3,764 | 3,038 | 3,559 | 3,191 | 3,405 | 2,830 | 3,355 |
| Revenue growth (YoY) | +11.7% | +10.6% | +7.4% | +6.1% | +5.4% | +1.7% | - | - |
| Other income | 172 | 173 | 175 | 141 | 140 | 144 | 141 | 129 |
| EBITDA | 632 | 741 | 461 | 719 | 588 | 667 | 427 | 682 |
| EBITDA margin | +17.7% | +19.7% | +15.2% | +20.2% | +18.4% | +19.6% | +15.1% | +20.3% |
| Depreciation | 119 | 121 | 122 | 117 | 115 | 114 | 117 | 109 |
| Interest | 39.59 | 36.63 | 39.97 | 31.12 | 39.68 | 34.63 | 39.25 | 44.20 |
| Profit before tax | 646 | 756 | 474 | 711 | 573 | 663 | 412 | 658 |
| Tax | 147 | 169 | 112 | 158 | 128 | 154 | 99.18 | 142 |
| Net profit | 499 | 586 | 362 | 554 | 445 | 508 | 313 | 516 |
| EPS (βΉ) | 2.84 | 3.33 | 2.08 | 3.15 | 2.55 | 2.90 | 1.80 | 2.94 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 9,383 | 9,071 | 9,136 | 8,684 | 8,180 | 7,185 | 6,310 |
| Revenue growth | +3.5% | -0.7% | +5.2% | +6.2% | +13.9% | +13.9% | - |
| EBITDA | 1,766 | 1,707 | 1,839 | 1,671 | 1,734 | 1,559 | 1,281 |
| EBITDA margin | +18.8% | +18.8% | +20.1% | +19.2% | +21.2% | +21.7% | +20.3% |
| Profit before tax | 1,901 | 1,808 | 1,967 | 1,829 | 1,896 | 1,683 | 1,408 |
| Net profit | 1,492 | 1,404 | 1,510 | 1,383 | 1,433 | 1,381 | 1,240 |
| Net profit margin | +15.9% | +15.5% | +16.5% | +15.9% | +17.5% | +19.2% | +19.7% |
| EPS (βΉ) | 8.41 | 7.92 | 8.52 | 7.75 | 8.11 | 7.82 | 6.62 |
| Balance sheet | |||||||
| Total assets | 8,211 | 7,866 | 7,757 | 6,965 | 6,485 | 5,628 | 4,784 |
| Net worth | 7,527 | 7,423 | 6,915 | 6,287 | 5,864 | 5,391 | 4,574 |
| Total debt | 611 | 379 | 776 | 615 | 560 | 180 | 151 |
| Cash & bank | 21.66 | 133 | 71.11 | 33.40 | 136 | 835 | 526 |
| Net working capital | (1,223) | (704) | (503) | (352) | (82.34) | 503 | 567 |
| Cash flow | |||||||
| Cash from operations | 1,885 | 1,623 | 1,653 | 1,562 | 1,320 | 1,704 | 1,155 |
| Cash from investing | (603) | (98.90) | (736) | (617) | (682) | (1,120) | (330) |
| Cash from financing | (1,293) | (1,511) | (922) | (940) | (635) | (555) | (826) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,433 | 2,687 | 2,132 | 2,547 | 2,235 | 2,470 | 1,965 | 2,448 |
| Revenue growth (YoY) | +8.9% | +8.8% | +8.5% | +4.1% | +4.3% | -1.8% | - | - |
| Other income | 128 | 131 | 147 | 108 | 106 | 116 | 119 | 105 |
| Total expenses | 1,974 | 2,152 | 1,815 | 2,007 | 1,811 | 1,984 | 1,680 | 1,926 |
| EBITDA | 459 | 536 | 317 | 540 | 424 | 485 | 284 | 523 |
| EBITDA margin | +18.9% | +19.9% | +14.9% | +21.2% | +19.0% | +19.6% | +14.5% | +21.3% |
| Depreciation | 65.74 | 67.08 | 67.26 | 66.25 | 64.13 | 63.19 | 63.22 | 63.78 |
| Interest | 26.50 | 21.72 | 23.27 | 22.16 | 19.60 | 17.28 | 22.84 | 28.33 |
| Profit before tax | 495 | 578 | 374 | 560 | 447 | 521 | 317 | 536 |
| Tax | 107 | 125 | 77.89 | 120 | 98.06 | 113 | 66.17 | 118 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3,563 | 3,764 | 3,038 | 3,559 | 3,191 | 3,405 | 2,830 | 3,355 |
| Revenue growth (YoY) | +11.7% | +10.6% | +7.4% | +6.1% | +5.4% | +1.7% | - | - |
| Other income | 172 | 173 | 175 | 141 | 140 | 144 | 141 | 129 |
| EBITDA | 632 | 741 | 461 | 719 | 588 | 667 | 427 | 682 |
| EBITDA margin | +17.7% | +19.7% | +15.2% | +20.2% | +18.4% | +19.6% | +15.1% | +20.3% |
| Depreciation | 119 | 121 | 122 | 117 | 115 | 114 | 117 | 109 |
| Interest | 39.59 | 36.63 | 39.97 | 31.12 | 39.68 | 34.63 | 39.25 | 44.20 |
| Profit before tax | 646 | 756 | 474 | 711 | 573 | 663 | 412 | 658 |
| Tax | 147 | 169 | 112 | 158 | 128 | 154 | 99.18 | 142 |
| Net profit | 499 | 586 | 362 | 554 | 445 | 508 | 313 | 516 |
| EPS (βΉ) | 2.84 | 3.33 | 2.08 | 3.15 | 2.55 | 2.90 | 1.80 | 2.94 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 13,193 | 12,563 | 12,404 | 11,530 | 10,889 | 9,562 | 8,685 |
| Revenue growth | +5.0% | +1.3% | +7.6% | +5.9% | +13.9% | +10.1% | - |
| Other income | 600 | 551 | 482 | 445 | 393 | 325 | 305 |
| Total expenses | 10,758 | 10,247 | 10,004 | 9,367 | 8,722 | 7,560 | 6,992 |
| Employee cost | 1,376 | 1,291 | 1,240 | 1,137 | 1,080 | 1,033 | 948 |
| EBITDA | 2,435 | 2,316 | 2,400 | 2,162 | 2,167 | 2,002 | 1,692 |
| EBITDA margin | +18.5% | +18.4% | +19.4% | +18.8% | +19.9% | +20.9% | +19.5% |
| Depreciation | 469 | 446 | 399 | 311 | 253 | 240 | 220 |
| Interest | 145 | 164 | 124 | 78.24 | 38.60 | 30.81 | 49.54 |
| Profit before tax | 2,420 | 2,258 | 2,359 | 2,219 | 2,269 | 2,056 | 1,728 |
| Tax | 552 | 517 | 547 | 517 | 526 | 361 | 280 |
| Net profit | 1,888 | 1,756 | 1,842 | 1,695 | 1,803 | 1,693 | 1,518 |
| Net profit margin | +14.3% | +14.0% | +14.9% | +14.7% | +16.6% | +17.7% | +17.5% |
| EPS (βΉ) | 10.68 | 9.97 | 10.40 | 9.64 | 9.84 | 9.58 | 8.18 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 177 | 177 | 177 | 177 | 177 | 177 | 177 |
| Reserves & surplus | 11,242 | 10,623 | 9,689 | 8,796 | 8,205 | 7,487 | 6,429 |
| Shareholders' funds (net worth) | 11,420 | 10,801 | 9,866 | 8,973 | 8,381 | 7,664 | 6,606 |
| Minority interest | 383 | 410 | 437 | 468 | 40.55 | 36.69 | 36.46 |
| Secured loans | 714 | 338 | 447 | 198 | 8.63 | 44.21 | 136 |
| Unsecured loans | 573 | 612 | 918 | 976 | 1,021 | 465 | 386 |
| Total debt | 1,287 | 950 | 1,365 | 1,174 | 1,030 | 509 | 522 |
| Total liabilities | 13,175 | 12,234 | 11,742 | 10,685 | 9,520 | 8,274 | 7,232 |
| Assets | |||||||
| Gross block | 7,161 | 6,756 | 6,215 | 5,583 | 4,041 | 3,779 | 3,629 |
| Net block | 3,938 | 3,990 | 3,815 | 3,579 | 2,308 | 2,243 | 2,253 |
| Capital work in progress | 139 | 169 | 232 | 175 | 168 | 147 | 147 |
| Investments | 8,947 | 7,468 | 6,933 | 6,265 | 6,220 | 4,160 | 2,800 |
| Inventories | 2,322 | 2,300 | 1,947 | 2,024 | 1,911 | 1,734 | 1,380 |
| Sundry debtors | 715 | 888 | 899 | 849 | 646 | 562 | 814 |
| Cash & bank balances | 562 | 578 | 666 | 326 | 570 | 1,329 | 811 |
| Loans & advances | 691 | 678 | 501 | 314 | 334 | 405 | 484 |
| Total current assets | 4,290 | 4,445 | 4,013 | 3,512 | 3,462 | 4,030 | 3,489 |
| Total current liabilities | 4,149 | 3,854 | 3,272 | 2,879 | 2,682 | 2,559 | 2,105 |
| Net working capital | 142 | 591 | 741 | 634 | 780 | 1,470 | 1,384 |
| Total assets | 13,175 | 12,234 | 11,742 | 10,685 | 9,520 | 8,274 | 7,232 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 112 | (21.18) | 97.57 | 227 | 189 | 91.74 | 37.72 |
| Net cash from operating activities | 2,579 | 1,987 | 2,013 | 1,488 | 1,802 | 2,115 | 1,614 |
| Net cash from investing activities | (1,279) | (448) | (971) | (583) | (1,273) | (1,404) | (517) |
| Net cash from financing activities | (1,236) | (1,405) | (1,161) | (1,035) | (490) | (613) | (1,043) |
| Net change in cash | 63.71 | 133 | (119) | (130) | 38.39 | 97.04 | 54.02 |
| Closing cash | 562 | 578 | 666 | 326 | 570 | 1,329 | 811 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +5.0% | +1.3% | +7.6% | +5.9% | +13.9% | +10.1% | - |
| EBITDA growth | +5.1% | -3.5% | +11.0% | -0.2% | +8.3% | +18.3% | - |
| PBT growth | +7.2% | -4.3% | +6.3% | -2.2% | +10.3% | +19.0% | +0.2% |
| Net income growth | +7.5% | -4.7% | +8.7% | -6.0% | +6.5% | +11.5% | - |
| Revenue CAGR (3Y) | +4.6% | +4.9% | +9.1% | +9.9% | +8.5% | +7.4% | +4.5% |
| EBITDA CAGR (3Y) | +4.0% | +2.3% | +6.2% | +8.5% | +9.2% | +7.7% | +3.9% |
| Profitability & leverage | |||||||
| Net income margin | +14.2% | +13.9% | +14.6% | +14.8% | +16.0% | +17.7% | +16.7% |
| Return on capital employed | +20.9% | +20.9% | +23.1% | +23.3% | +26.1% | +27.0% | +26.2% |
| Return on net worth | +16.8% | +16.8% | +19.2% | +19.6% | +21.7% | +23.8% | +23.7% |
| Debt / equity | 0.10 | 0.11 | 0.13 | 0.13 | 0.10 | 0.07 | 0.10 |
| Long-term debt / equity | 0.03 | 0.06 | 0.06 | 0.05 | 0.03 | 0.02 | 0.02 |
| Interest cover | 7.40 | 8.74 | 6.21 | 4.23 | 2.02 | 1.75 | 3.37 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.90 | 1.94 | 2.10 | 2.40 | 2.78 | 2.58 | 2.57 |
| Inventory turnover | 5.71 | 5.92 | 6.25 | 5.86 | 5.97 | 6.14 | 6.49 |
| Debtors turnover | 16.45 | 14.06 | 14.20 | 15.43 | 18.03 | 13.90 | 10.57 |
| EPS (βΉ) | 10.68 | 9.97 | 10.40 | 9.64 | 9.84 | 9.58 | 8.18 |
| Dividend per share (βΉ) | 8.25 | 8.00 | 5.50 | 5.20 | 5.20 | 4.75 | 3.00 |
| Book value per share (βΉ) | 64.38 | 60.94 | 55.68 | 50.64 | 47.41 | 43.36 | 37.38 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,433 | 2,687 | 2,132 | 2,547 | 2,235 | 2,470 | 1,965 | 2,448 |
| Revenue growth (YoY) | +8.9% | +8.8% | +8.5% | +4.1% | +4.3% | -1.8% | - | - |
| Other income | 128 | 131 | 147 | 108 | 106 | 116 | 119 | 105 |
| Total expenses | 1,974 | 2,152 | 1,815 | 2,007 | 1,811 | 1,984 | 1,680 | 1,926 |
| EBITDA | 459 | 536 | 317 | 540 | 424 | 485 | 284 | 523 |
| EBITDA margin | +18.9% | +19.9% | +14.9% | +21.2% | +19.0% | +19.6% | +14.5% | +21.3% |
| Depreciation | 65.74 | 67.08 | 67.26 | 66.25 | 64.13 | 63.19 | 63.22 | 63.78 |
| Interest | 26.50 | 21.72 | 23.27 | 22.16 | 19.60 | 17.28 | 22.84 | 28.33 |
| Profit before tax | 495 | 578 | 374 | 560 | 447 | 521 | 317 | 536 |
| Tax | 107 | 125 | 77.89 | 120 | 98.06 | 113 | 66.17 | 118 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 9,383 | 9,071 | 9,136 | 8,684 | 8,180 | 7,185 | 6,310 |
| Revenue growth | +3.5% | -0.7% | +5.2% | +6.2% | +13.9% | +13.9% | - |
| Other income | 478 | 452 | 418 | 392 | 342 | 277 | 277 |
| Total expenses | 7,617 | 7,364 | 7,297 | 7,013 | 6,446 | 5,626 | 5,029 |
| Employee cost | 814 | 777 | 782 | 726 | 679 | 656 | 578 |
| EBITDA | 1,766 | 1,707 | 1,839 | 1,671 | 1,734 | 1,559 | 1,281 |
| EBITDA margin | +18.8% | +18.8% | +20.1% | +19.2% | +21.2% | +21.7% | +20.3% |
| Depreciation | 261 | 251 | 209 | 188 | 160 | 143 | 130 |
| Interest | 82.31 | 99.58 | 81.14 | 46.37 | 18.67 | 9.14 | 19.27 |
| Profit before tax | 1,901 | 1,808 | 1,967 | 1,829 | 1,896 | 1,683 | 1,408 |
| Tax | 409 | 405 | 457 | 455 | 463 | 301 | 238 |
| Net profit | 1,492 | 1,404 | 1,510 | 1,383 | 1,433 | 1,381 | 1,240 |
| Net profit margin | +15.9% | +15.5% | +16.5% | +15.9% | +17.5% | +19.2% | +19.7% |
| EPS (βΉ) | 8.41 | 7.92 | 8.52 | 7.75 | 8.11 | 7.82 | 6.62 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 177 | 177 | 177 | 177 | 177 | 177 | 177 |
| Reserves & surplus | 7,349 | 7,246 | 6,738 | 6,110 | 5,687 | 5,214 | 4,398 |
| Shareholders' funds (net worth) | 7,527 | 7,423 | 6,915 | 6,287 | 5,864 | 5,391 | 4,574 |
| Secured loans | 196 | 0.10 | 99.99 | 178 | 0.00 | 26.94 | 101 |
| Unsecured loans | 415 | 379 | 676 | 438 | 560 | 153 | 49.46 |
| Total debt | 611 | 379 | 776 | 615 | 560 | 180 | 151 |
| Total liabilities | 8,211 | 7,866 | 7,757 | 6,965 | 6,485 | 5,628 | 4,784 |
| Assets | |||||||
| Gross block | 3,962 | 3,722 | 3,345 | 2,938 | 2,501 | 2,168 | 1,982 |
| Net block | 2,051 | 2,036 | 1,878 | 1,662 | 1,399 | 1,205 | 1,134 |
| Capital work in progress | 110 | 137 | 184 | 109 | 128 | 107 | 106 |
| Investments | 7,248 | 6,359 | 6,148 | 5,475 | 5,007 | 3,574 | 2,467 |
| Inventories | 1,365 | 1,288 | 1,150 | 1,224 | 1,238 | 1,114 | 809 |
| Sundry debtors | 473 | 601 | 719 | 561 | 455 | 281 | 380 |
| Cash & bank balances | 21.66 | 133 | 71.11 | 33.40 | 136 | 835 | 526 |
| Loans & advances | 334 | 280 | 232 | 140 | 126 | 149 | 168 |
| Total current assets | 2,193 | 2,302 | 2,172 | 1,959 | 1,955 | 2,379 | 1,883 |
| Total current liabilities | 3,416 | 3,006 | 2,675 | 2,311 | 2,037 | 1,876 | 1,316 |
| Net working capital | (1,223) | (704) | (503) | (352) | (82.34) | 503 | 567 |
| Total assets | 8,211 | 7,866 | 7,757 | 6,965 | 6,485 | 5,628 | 4,784 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 24.16 | 10.77 | 15.35 | 10.47 | 7.01 | (21.75) | (20.24) |
| Net cash from operating activities | 1,885 | 1,623 | 1,653 | 1,562 | 1,320 | 1,704 | 1,155 |
| Net cash from investing activities | (603) | (98.90) | (736) | (617) | (682) | (1,120) | (330) |
| Net cash from financing activities | (1,293) | (1,511) | (922) | (940) | (635) | (555) | (826) |
| Net change in cash | (10.63) | 13.39 | (4.58) | 4.88 | 3.46 | 28.76 | (1.51) |
| Closing cash | 21.66 | 133 | 71.11 | 33.40 | 136 | 835 | 526 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +3.5% | -0.7% | +5.2% | +6.2% | +13.9% | +13.9% | - |
| EBITDA growth | +3.5% | -7.2% | +10.1% | -3.6% | +11.2% | +21.7% | - |
| PBT growth | +5.1% | -8.1% | +7.6% | -3.6% | +12.7% | +19.5% | -6.3% |
| Net income growth | +6.3% | -7.0% | +9.2% | -3.5% | +3.8% | +11.4% | - |
| Revenue CAGR (3Y) | +2.6% | +3.5% | +8.3% | +11.2% | +9.3% | +8.7% | +6.1% |
| EBITDA CAGR (3Y) | +1.9% | -0.5% | +5.7% | +9.3% | +8.2% | +8.7% | +4.8% |
| Profitability & leverage | |||||||
| Net income margin | +15.9% | +15.5% | +16.5% | +15.8% | +17.5% | +19.2% | +18.6% |
| Return on capital employed | +24.7% | +24.4% | +27.8% | +27.9% | +31.6% | +32.5% | +31.3% |
| Return on net worth | +20.0% | +19.6% | +22.9% | +22.6% | +25.5% | +27.7% | +27.4% |
| Debt / equity | 0.07 | 0.08 | 0.11 | 0.10 | 0.07 | 0.03 | 0.05 |
| Long-term debt / equity | 0.03 | 0.06 | 0.06 | 0.05 | 0.03 | 0.00 | 0.01 |
| Interest cover | 5.47 | 6.84 | 4.98 | 3.13 | 1.19 | 0.65 | 1.67 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.44 | 2.57 | 2.91 | 3.19 | 3.50 | 3.46 | 3.36 |
| Inventory turnover | 7.07 | 7.44 | 7.70 | 7.06 | 6.96 | 7.47 | 8.18 |
| Debtors turnover | 17.48 | 13.75 | 14.27 | 17.10 | 22.23 | 21.74 | 15.56 |
| EPS (βΉ) | 8.41 | 7.92 | 8.52 | 7.75 | 8.11 | 7.82 | 6.62 |
| Dividend per share (βΉ) | 8.25 | 8.00 | 5.50 | 5.20 | 5.20 | 4.75 | 3.00 |
| Book value per share (βΉ) | 42.44 | 41.89 | 39.03 | 35.48 | 33.17 | 30.50 | 25.89 |
Investments & Acquisitions by Dabur
Dabur has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Asian Consumer Care, Badshah Masala and Balsara Home Products.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Ayurvedic hair care and wellness products are manufactured naturally. | sesacare.com | Thane, India | 1995 | Oct 2024 | $1.5M | |
Blended, ground, and whole spices are manufactured for culinary applications. | badshahmasala.com | Mumbai, India | 1958 | Oct 2022 | $18.77M | |
Retailer of personal care products | 0 | Jul 2022 | β’β’β’β’ | |||
Hair care products are developed and marketed for renewal needs. | orshaircare.com | Chicago, United States | 1996 | Nov 2010 | $100M | |
Manufacturer of hair, body, and skin care products | hobikozmetik.com | Istanbul, Turkey | 1974 | Jul 2010 | $69.84M | |
Telecommunication industry products are provided by Balsara Home Products. | balsara.com | Mumbai, India | 1925 | Jan 2005 | β’β’β’β’ |
Complete acquisition details for Dabur
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Dabur
10 dated milestones of Dabur across 140 years, from founding to its latest funding, stage changes and deals.
- Founded Dabur is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Balsara Home Products.
- Acquisition Acquires Hobi Kozmetik.
- Acquisition Acquires ORS Hair Care.
- Funding First funding round of $45.0M.
- Acquisition Acquires Asian Consumer Care.
- Acquisition Acquires Badshah Masala.
- Funding Latest funding round, Angel Round, of $9.0M.
- Acquisition Acquires Sesa Care.
Competitors of Dabur
Dabur has 3 listed competitors in our database, 2 of them funded. They include Mamaearth, WOW Skin Science and The Body Shop India.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mamaearth.in | 2016 | Gurugram, India | $89.36M | 1,900 | Online brand offering multi-category natural skin care and makeup products | |
| buywow.in | 2014 | Bengaluru, India | $98M | 100 | Organic beauty products are offered by an internet-first brand. | |
| thebodyshop.in | 2006 | Gurugram, India | 861 | Cruelty-free beauty and body care products are retailed in India. |
Detailed competitors of Dabur
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Dabur
The website of Dabur (dabur.com) receives about 387.5K visits a month and ranks #143,847 among all websites worldwide, #4,403 in Health.
- Monthly visits387.5K
▲ 25.1% vs previous month
- Unique visitors112.9K
per month
- Global rank#143,847
among all websites
- Category rank#4,403
Health · Health
- Bounce rate40%
- Pages per visit3.4
- Average visit4 min 16 sec
- DevicesDesktop 46% Β· Mobile 54%
Websites whose visitors overlap most with Dabur. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cipla.com | 100% | 200.9K | #203,362 | View details | |
| drreddys.com | 98% | 118.8K | #308,607 | View details | |
| baidyanath.com | 88% | View details | |||
| zanduayurveda.com | 85% | View details | |||
| himalayahealthcare.com | 85% | View details | |||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Dabur
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Beauty & Personal Care Products
3 companies that operate in the same segment as Dabur (Beauty & Personal Care Products) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Online platform offering a wide range of baby, kids, and maternity products | 2010 | Pune, Maharashtra, India | USD 513.39 M | USD 911.07 M | 3,752 | |
Online brand offering mens grooming products | 2015 | Gurugram, Haryana, India | USD 52.66 M | |||
Retailer of perfumes, cosmetics, skincare, and related gift set items | 2012 | Gurugram, Haryana, India | USD 60.63 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dabur
Complete news archive for Dabur
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Articles about Dabur on our blog
- Top FMCG Trends For 202014 Dec 2020
Frequently Asked Questions about Dabur
Dabur was founded in 1884 and raised its 1st funding round 128 years after it was founded.
Dabur is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Mohit Malhotra is the CEO of Dabur, as recorded in our data.
Dabur is a funded company, having raised a total of $42.18M across 4 funding rounds to date. The company's 1st funding round was a Post-IPO of $45M, raised on Jun 2012.
Dabur has 4,770 employees.
The primary company behind Dabur, Dabur India Limited, reported revenue of βΉ9,861 Cr for FY 2026, up 5% year on year.
Dabur was founded in 1884 in Delhi, India, and operates in the ayurvedic medicine and natural consumer products sector. A diverse portfolio is produced, encompassing skincare, haircare, healthcare, and oral care items. Offerings include hair oil, toothpaste, churna, chyawanprash, honey, rose water, tea, cough syrup, health juices, skin care products, and baby care essentials. Operations focus on traditional formulations for everyday health and personal needs.
Dabur's top competitors include Mamaearth, The Body Shop India and WOW Skin Science.
Yes, Dabur is publicly traded on NSE under the ticker symbol DABUR.
Dabur has made 6 acquisitions, including Asian Consumer Care, Badshah Masala, and Balsara Home Products.
Dabur has 1 investor. Key investors include Baring Private Equity Partners.
Dabur is associated with 6 legal entities: Dabur India Limited, Dabur Securities Private Limited, Malhotras Trading Co Pvt Ltd and others.
